The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
EAHP held 2 Academy Seminars in Warsaw, Poland
between 19 October – 21 October 2018.
Seminar 1: Medicines Shortages – Causation and Approaches to Improvements
This seminar will address the below preliminary topics:
- Stakeholders
- Causes / Erroneous incentives
- Impacts on Outcomes:
- Clinical outcomes,
- Economic outcome,
- Patients Interests (QoL).
- Approach to improvements:
- Systems Dynamics,
- Manufacturing and preparation,
- Resolution, Guidelines or reglementation?
Seminar 2: Therapeutic Drug Monitoring as a Tool for Therapy Optimisation
This seminar will address the below preliminary topics:
- Concept of Therapeutic drug monitoring (TDM) and practical consideration
- Population pharmacokinetic analysis of TDM in optimising therapy
- TDM and:
- Dose optimisation of antibiotics and antimycotics,
- Dose optimisation of antiepileptic and antipsychotic drugs,
- Dose optimisation of immunosuppressives and anticancer drugs.
Advertisement: EAHP thanks the continued support of our Platinum Partners, Amgen, Bayer, Pfizer, BMS Pfizer Alliance, and our Corporate Partners, Omnicell and MSD.
Platinum partners Corporate partners
Other sponsors